ANCA-Associated Vasculitis: An Update
Fussner, Lynn A.
Meara, Alexa S.
Journal of Clinical Medicine
MetadataShow full item record
Almaani, S., Fussner, L. A., Brodsky, S., Meara, A. S., & Jayne, D. (2021). ANCA-Associated Vasculitis: An Update. Journal of Clinical Medicine, 10 (7)https://doi.org/10.3390/jcm10071446
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) represents a group of small vessel vasculitides characterized by granulomatous and neutrophilic tissue inflammation, often associated with the production of antibodies that target neutrophil antigens. The two major antigens targeted by ANCAs are leukocyte proteinase 3 (PR3) and myeloperoxidase (MPO). AAV can be classified into 3 categories based on patterns of clinical involvement: namely, granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and eosinophilic GPA (EGPA). Clinically, AAV involves many organ systems including the lungs, kidneys, skin, and nervous system. The prognosis of AAV has improved dramatically due to advances in the understanding of its pathogenesis and treatment modalities. This review will highlight some of the recent updates in our understanding of the pathogenesis, clinical manifestations, and treatment options in patients with AAV focusing on kidney involvement.
ANCA vasculitis, review, vasculitis, crescentic glomerulonephritis
External DOI: https://doi.org/10.3390/jcm10071446
This record's URL: https://www.repository.cam.ac.uk/handle/1810/319467